Status:
UNKNOWN
Tragal Perichondrium Versus Pretragal Fascial (SMAS) Graft for Endoscopic Myringoplasty
Lead Sponsor:
Assiut University
Conditions:
Tympanic Membrane Perforation
Eligibility:
All Genders
16-50 years
Phase:
NA
Brief Summary
1. Examine the treatment outcomes of the pretragal (SMAS) fascia as a new graft when used in endoscopic myringoplasty. 2. Compare the results when using the tragal pericondrium as a graft in endoscopi...
Detailed Description
The exclusive transcanal endoscopic tympanoplasty technique emerged in the1990s : it provides a more direct and wider surgical viewing angle, largely reduces the necessity for a traumatic postauricula...
Eligibility Criteria
Inclusion
- Above 16 yrs old and less than 50 yrs old.
- Clinically diagnosed central tympanic membrane perforations or chronic suppurative otitis media (tubo-tympanic).
- Dry ear: no otorrhea without medication for at least 1 month.
- Hearing loss gap not more than 50dB
Exclusion
- Age less than 16 or more than 50.
- Discharging (active) central perforations.
- Unsafe CSOM with cholesteatoma.
- Suspected ossicular pathology in safe CSOM if the gap \> 50dB.
- Previous ear surgery.
- Patients unfit for surgery or having chronic medical illness.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04687995
Start Date
January 1 2021
End Date
November 1 2022
Last Update
January 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.